Interim Results of a Phase II/III Multicenter Randomized Clinical Trial of AVIFAVIR in Hospitalized Patients with COVID-19
- Resource Type
- Source
- Subject
medicine.medical_specialty Coronavirus disease 2019 (COVID-19) business.industry Favipiravir Marketing authorization law.invention Clinical trial Randomized controlled trial law RNA Polymerase Inhibitor Internal medicine Interim Medicine Christian ministry business - Language
- English